A new model of dual interacting ligand binding sites on integrin αIIbβ3

被引:58
作者
Hu, DD
White, CA
Panzer-Knodle, S
Page, JD
Nicholson, N
Smith, JW
机构
[1] La Jolla Canc Res Fdn, Canc Res Ctr, Program Cell Adhes, Burnham Inst, La Jolla, CA 92037 USA
[2] Searle, Dept Cardiovasc Dis Res, Skokie, IL 60077 USA
关键词
D O I
10.1074/jbc.274.8.4633
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The platelet integrin alpha(IIIb)beta(3) mediates platelet aggregation and platelet adhesion. This integrin is the key to hemostasis and also to pathologic vascular occlusion. A key domain on alpha(IIIb)beta(3) is the ligand binding site, which can bind to plasma fibrinogen and to a number of Arg-Gly-Asp (RGD)-type ligands. However, the nature and function of the ligand binding pocket on alpha(IIIb)beta(3) remains controversial. Some studies suggest the presence of two ligand binding pockets, whereas other reports indicate a single binding pocket. Here we use surface plasmon resonance to show that alpha(IIb)beta(3) contains two distinct ligand binding pockets. One site binds to fibrinogen, and a separate site binds to RGD-type ligands, More importantly, however, the two ligand binding pockets are interactive. RGD-type ligands are capable of binding to alpha(IIb)beta(3) even when it is already occupied by fibrinogen, Once bound, RGD-type ligands induce the dissociation of fibrinogen from alpha(IIb)beta(3). This allosteric cross-talk has important implications for anti-platelet therapy because it suggests a novel approach for the dissolution of existing platelet thrombi.
引用
收藏
页码:4633 / 4639
页数:7
相关论文
共 48 条
[1]   INTEGRINS AND OTHER CELL-ADHESION MOLECULES [J].
ALBELDA, SM ;
BUCK, CA .
FASEB JOURNAL, 1990, 4 (11) :2868-2880
[2]   DETERMINATION OF KINETIC CONSTANTS FOR THE INTERACTION BETWEEN A MONOCLONAL-ANTIBODY AND PEPTIDES USING SURFACE-PLASMON RESONANCE [J].
ALTSCHUH, D ;
DUBS, MC ;
WEISS, E ;
ZEDERLUTZ, G ;
VANREGENMORTEL, MHV .
BIOCHEMISTRY, 1992, 31 (27) :6298-6304
[3]   HIGH-AFFINITY SELF-REACTIVE HUMAN-ANTIBODIES BY DESIGN AND SELECTION - TARGETING THE INTEGRIN LIGAND-BINDING SITE [J].
BARBAS, CF ;
LANGUINO, LR ;
SMITH, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10003-10007
[4]  
BEER JH, 1992, BLOOD, V79, P117
[5]  
BENNETT JS, 1988, J BIOL CHEM, V263, P12948
[6]   Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity [J].
Brooks, PC ;
Silletti, S ;
von Schalscha, TL ;
Friedlander, M ;
Cheresh, DA .
CELL, 1998, 92 (03) :391-400
[7]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[8]   Networking in the hemostatic system - Integrin alpha(IIIb)beta(3) binds prothrombin and influences its activation [J].
Byzova, TV ;
Plow, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27183-27188
[9]  
Coller BS, 1997, CIRCULATION, V95, P860
[10]   Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics [J].
Coller, BS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1467-1471